Silverback Therapeutics prices IPO at $21/share, will raise $241M in 4th Wash. state IPO of 2020

Retrieved on: 2020-12-04 04:30:00

Tags for this article:

Click the tags to see associated articles and topics

Silverback Therapeutics prices IPO at $21/share, will raise $241M in 4th Wash. state IPO of 2020. View article details on hiswai:

Excerpt

Its lead product candidate, designated SBT6050, uses <b>monoclonal antibodies</b> to target breast, gastric and lung cancers. It's currently in Phase 1/1b ...

Article found on: www.geekwire.com

View Original Article